Página 3 - Melhores Cancro do fígado estádio 3 médicos - TOP-86 médicos

Diretor de internação oncológica no Tel Aviv Medical Center – o Dr. Stepfansky lidera o tratamento do câncer de fígado em um dos principais hospitais de Israel.

• Especializar-se em oncologia com mais de 15 anos de experiência
• Investigador principal em ensaios clínicos para novos tratamentos de câncer
• Formar-se no Hospital Ichilov – um centro de oncologia de referência

O Dr. Alemdar é especialista no tratamento do cancro do fígado, com uma sólida formação académica e vasta experiência hospitalar.

• Mais de 15 anos de experiência em medicina interna e oncologia
• Formação em oncologia médica na Faculdade de Medicina da Universidade Akdeniz
• Trabalhou em múltiplos hospitais de referência na Turquia
• Membro da Associação Turca de Oncologia Médica

O Prof. Univ. Dr. Wolfgang Köstler é um oncologista médico reconhecido internacionalmente, com mais de 20 anos de experiência em terapia sistémica do cancro.

• Focar-se no tratamento personalizado utilizando terapias direcionadas e imunoterapia
• Chefe Adjunto da Divisão Clínica de Oncologia da Universidade Médica de Viena
• Realizar investigação de translação para adequar os tratamentos à biologia do tumor
• Especialista em cancros da mama e ginecológicos com um sólido percurso académico
• Consultor sénior na prestigiada Wiener Privatklinik

O Professor Associado Dr. Yusuf Acikgoz traz a sua experiência da Ohio State University – liderando agora casos de oncologia no Hospital Universitário Lokman Hekim em Ancara.

• Especializado em Oncologia Médica com mais de 7 anos de formação focada
• Participação em ensaios clínicos internacionais de Fase III para tratamentos avançados de cancro
• Fluente em inglês com múltiplas certificações internacionais
• Membro da American Society of Clinical Oncology

O Professor Associado Tahsin Ozatli é especialista em cancros da mama, do pulmão e gastrointestinais no Hospital Universitário Istinye Liv.

• Mais de 10 anos de experiência em oncologia
• Especializar-se em casos de cancro complexos
• Trabalhar na Clínica de Oncologia de Ancara e em outros hospitais de referência
• Ser promovido a Professor Associado em 2016

Dr. Liuying leads the Oncology Ward at Jinshazhou Hospital, Guangzhou University of Chinese Medicine. Clinical focus includes hepatocellular carcinoma, cholangiocarcinoma, and lung and colorectal cancers. Dr. Liuying has special expertise in melanoma and melanoma liver metastasis. Interventional skills include MWA, RFA, cryoablation, and radioactive seed implantation for non-vascular, minimally invasive tumor ablation.

Research: participated in two Guangdong Provincial science and technology projects. Contributed to the 2014 Expert Consensus for Thermal Ablation of Primary and Metastatic Lung Tumors. Published in the Chinese Journal of Lung Cancer. Compiled Selected Cases of Microwave Ablation for Lung Tumors and Selected Cases of Microwave Ablation for Liver Tumors.

Appointments: Standing Committee Member, Youth Committee of Intra-Tumor Brachytherapy Medicine, China Medical Education Association. Standing Committee Member, Minimally Invasive Interventional Medicine Professional Committee, Guangdong Primary Medical Association.

Assoc. Prof. Atakan Topçu, M.D., is a medical oncologist at Medipol University and Medipol Acıbadem Regional Hospital. He treats solid tumors, including lung, breast, colorectal, gastric, and neuroendocrine cancers. His work also covers targeted therapies, immunotherapy, geriatric oncology, and cancer-related malnutrition, cachexia, and sarcopenia.

He has authored more than 50 peer-reviewed papers. Recent work includes a 2024 Frontiers in Medicine study on geriatric syndromes and a 2023 Future Oncology paper on sarcopenia and anxiety in lung cancer. He has also published on the CONUT score in breast cancer and on malnutrition in HER2-negative metastatic gastric cancer.

Dr. Topçu serves on the Editorial Board of BMC Cancer. He is a member of the Turkish Society of Medical Oncology, ESMO, and the Turkish Geriatrics Society. Education and training: M.D., Uludağ University; residency in Internal Medicine, Marmara University; fellowship in Medical Oncology, Bezmialem Vakıf University.

O Professor Associado Nail Paksoy é especialista em cancro do fígado no Hospital Medipol Bahçelievler, com vasta investigação em oncologia.

• Certificado pelo Conselho da ESMO em Oncologia Médica
• Participar ativamente em ensaios clínicos internacionais para tratamentos de cancro
• Publicar vários artigos de investigação sobre diversos tipos de cancro
• Formação especializada no Instituto de Oncologia da Universidade de Istambul

Especializado em cirurgia laparoscópica avançada e oncológica nos prestigiados hospitais da Universidade de Istambul. Realiza técnicas minimamente invasivas para casos complexos de cancro do fígado.

• Certificado pela ordem com mais de 30 anos de experiência cirúrgica
• Formação especializada em cirurgia laparoscópica de antirefluxo e bariátrica
• Especialização avançada em técnicas de cirurgia oncológica
• Realização de cirurgias nos Hospitais Büyük Anadolu

Professor Shixin Liu, MD, PhD, is the Discipline Leader of the Oncology Center. He is the former President of Jilin Provincial Cancer Hospital and former Director of the Cancer Prevention and Treatment Research Institute. He is a second-level professor and doctoral supervisor. He has received the State Council Special Government Allowance, the 4th National Famous Doctor (Outstanding Contribution) award, and the Model of Medical Ethics honor.

He specializes in the comprehensive diagnosis and treatment of malignant tumors. His focus is precision radiotherapy for thoracic and abdominal cancers. He is skilled in IMRT, VMAT, and SBRT for lung, esophageal, breast, and rectal cancers.

His leadership roles include Vice Chair of CMA Radiation Oncology, CACA Radiotherapy, and CACA Particle Therapy. He serves on the CSCO Standing Committee and as Vice Chair of the CSCO Radiation Oncology Expert Committee. He is Vice Chair of CPAM Radiation Oncology and a Standing Committee member of CSMEA. He chairs the Jilin Medical Association Radiation Oncology branch. He is on the editorial boards of the Chinese Journal of Radiation Oncology and the Practical Journal of Cancer.

Especialista no tratamento do cancro do fígado com vasta experiência em oncologia médica. O Dr. Ozden foca-se no atendimento personalizado para pacientes com cancro do fígado de estágio 3 no Hospital VM Medical Park Pendik.

• 6 anos de subespecialização em oncologia médica na Faculdade de Medicina da Universidade de Kocaeli
• Mais de 16 anos de experiência em medicina interna e oncologia
• Formado na Faculdade de Medicina Cerrahpaşa da Universidade de Istambul – uma das melhores faculdades de medicina da Turquia

Dr. Mariam Mohammed Hussein Abu Zeid is a clinical oncologist. She treats solid tumors and hematologic cancers. She earned her MBBCh from Ain Shams University in 2007 (Excellent). She completed a Master’s in Clinical Oncology and Nuclear Medicine in 2011 (Very Good). She received a Ph.D. in 2018 and an ESMO Certificate in 2015.

She leads and monitors clinical trials. Her work includes data collection and analysis. She administers chemotherapy and manages treatment toxicities. She also plans care with multidisciplinary teams. Her experience includes Ain Shams University Hospitals (2009–2012), the International Medical Center (2012–2014), and Wadi El Nile Hospital (2015–2019). Her roles covered diagnosis and staging, supportive care, quality improvement, and screening. She educates patients and families about the diagnosis, treatment options, and palliative care.

Dr. Irfan Cicin is a Professor of Medical Oncology at the Trakya University Faculty of Medicine (2015–present). He has over 20 years of medical oncology experience and has held academic roles since 2010.

Education: MD, Istanbul University – Cerrahpaşa (1991–1997). Residency in Internal Medicine, Trakya University (1997–2002). Fellowship in Medical Oncology, Trakya University (2002–2004).

Practice: Medical Oncologist, Trakya University (2005–2008). Medical Oncologist, Elazığ Training and Research Hospital (2008–2010). Associate Professor of Medical Oncology, Trakya University (2010–2015). He previously served as a physician in the Turkish Air Force at Etimesgut Military Hospital (2004–2005).

Especializada em viroterapia – uma abordagem de imunoterapia de ponta para o cancro do fígado – a Dra. Jaunalksne traz mais de 30 anos de experiência em imunologia.

• Chefe do Centro de Imunologia Clínica do Hospital Universitário Clínico Pauls Stradins
• Licenciada pelo Instituto Médico de Riga com internato em Medicina Interna
• Focar-se em imunoterapias inovadoras para o tratamento do cancro

O Dr. Auala Hubert chefia o Centro de Cancro Gastrointestinal do Hadassah Medical Center, com 33 anos de experiência em oncologia e radioterapia.

• Especializar-se em oncologia médica e radioterapia para cancro do fígado
• Médico sénior no Departamento de Oncologia do Hospital Universitário Hadassah
• Formação na Universidade Hebraica e no Hospital Universitário Hadassah
• Membro da Sociedade Israelita de Oncologia Clínica e da Associação de Cancro

O Professor Associado Babek Tabandeh é especialista em cirurgia de cancro do fígado e técnicas minimamente invasivas no Hospital Medical Park Goztepe.

• Mais de 30 anos de experiência em cirurgia geral
• Autor de mais de 40 documentos médicos
• Membro do American College of Surgeons e da Liver Transplantation Society
• Leciona na Faculdade de Medicina da Universidade Bahçeşehir

Dr. Muhammed Mustafa Atci is an Associate Professor of Medical Oncology at İstinye University, Liv Hospital Topkapı (2025–present). He previously served as Associate Professor and Education Coordinator at Prof. Dr. Cemil Taşcıoğlu City Hospital (2023–2025). He was also a Medical Oncologist there (2018–2021).

He has been a member of ASCO and the Turkish Society of Medical Oncology since 2018. He is the author or co-author of 19 peer-reviewed international papers on colon, breast, gastric, pancreatic, lung, thyroid, sarcoma, and colorectal cancers.

Notable works include a multicentre study on stage IIB colon cancer survival (Journal of Chemotherapy). He also studied the De Ritis ratio for lung metastasis in testicular cancer (Current Urology). His prognostic studies used PET/CT, MSI, lymph node ratio, and metabolic tumor volume.

Dr. Maha Yahia is a medical oncologist and hemato-oncologist. She provides assessment, diagnosis, and treatment planning. Her treatments include chemotherapy, targeted therapy, and immunotherapy. She cares for patients with breast, genitourinary, gynecologic, thoracic, gastrointestinal, and rare cancers.

Education: M.B.B.Ch, Kasr El-Aini, Cairo University (1997–2003). Master in Hemato-oncology, National Cancer Institute, Cairo University (2008). Doctoral Degree in Hemato-oncology, National Cancer Institute, Cairo University (2015).

Experience: Resident in Medical Oncology, Maadi AFMC (2005–2010). Visitor Resident, NCI Cairo (2008–2009). Consultant Assistant, Prof. Hussein Khaled Clinic (2010–2017). Specialist, International Medical Center (2011–2012), Wadi El Nile Hospital (2013–2014), and Maadi AFMC (2011–2018). Head, Clinical Research Support Team, Maadi AFMC (2016–2018). Major (2014–2016) and Lt. Colonel Doctor (2016–2018), Egyptian Armed Forces. Lecturer of Clinical Research, AFCM (2019–2021).